Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Holding SRPT?
Track your performance easily

Sarepta Therapeutics (SRPT) Technical Analysis

2,981 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Sarepta Therapeutics’s (SRPT) Moving Averages Convergence Divergence (MACD) indicator is -3.90, suggesting Sarepta Therapeutics is a Buy.
Sarepta Therapeutics’s (SRPT) 20-Day exponential moving average is 131.38, while Sarepta Therapeutics’s (SRPT) share price is $125.69, making it a Sell.
Sarepta Therapeutics’s (SRPT) 50-Day exponential moving average is 135.30, while Sarepta Therapeutics’s (SRPT) share price is $125.69, making it a Sell.

Sarepta Therapeutics (SRPT) Pivot Points

Sep 20, 2024, 12:41 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
120.52
122.21
123.27
124.97
126.03
127.72
128.78
Fibonacci
122.21
123.27
123.92
124.97
126.02
126.67
127.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sarepta Therapeutics (SRPT) Moving Averages

Sep 20, 2024, 12:41 AM
Period
Simple
Exponential
MA5
125.68Buy
125.93Sell
MA10
128.05Sell
128.07Sell
MA20
133.72Sell
131.38Sell
MA50
139.04Sell
135.30Sell
MA100
136.07Sell
133.94Sell
MA200
125.97Sell
125.09Buy
Sarepta Therapeutics’s (SRPT) 10-Day exponential moving average is 128.07, while Sarepta Therapeutics’s (SRPT) share price is $125.69, making it a Sell.
Sarepta Therapeutics’s (SRPT) 100-Day exponential moving average is 133.94, while Sarepta Therapeutics’s (SRPT) share price is $125.69, making it a Sell.
Sarepta Therapeutics’s (SRPT) stock price is $125.69 and Sarepta Therapeutics’s (SRPT) 50-day simple moving average is 139.04, creating a Sell signal.
Sarepta Therapeutics’s (SRPT) stock price is $125.69 and Sarepta Therapeutics’s (SRPT) 100-day simple moving average is 136.07, creating a Sell signal.
Sarepta Therapeutics’s (SRPT) stock price is $125.69 and Sarepta Therapeutics’s (SRPT) 200-day simple moving average is 125.97, creating a Sell signal.

Sarepta Therapeutics (SRPT) Technical Indicators

Sep 20, 2024, 12:41 AM
Name
Value
Implied Action
RSI (14)
33.69
Neutral
STOCH (9,6)
28.25
Neutral
STOCHRSI (14)
21.51
Neutral
MACD (12,26)
-3.90
Buy
ADX (14)
27.46
Neutral
Williams %R
-74.36
Buy
CCI (14)
-92.47
Neutral
ATR (14)
3.96
-
Ultimate Oscillator
48.11
Neutral
ROC
-10.64
Sell
Sarepta Therapeutics’s (SRPT) Relative Strength Index (RSI) is 33.69, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Trend Strength Indicator (ADX) is 27.46, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Commodity Channel Index (CCI) is -92.47, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Price Rate of Change (ROC) is -10.64, creating a Sell signal.

FAQ

Is SRPT a Buy, Hold, or Sell?
Based on SRPT’s technical indicators, SRPT is a Sell.
    What is SRPT’s RSI (14)?
    SRPT’s RSI (14) is 33.69, which suggests SRPT is a Neutral.
      What is SRPT’s MACD?
      SRPT’s MACD is -3.90, which suggests SRPT is a Buy.
        What is SRPT’s 5-day moving average?
        SRPT’s 5-day moving average is 125.68, which suggests SRPT is a Buy.
          What is SRPT’s 20-day moving average?
          SRPT 20-day moving average is 133.72, which suggests SRPT is a Sell.
            What is SRPT’s 50-day moving average?
            SRPT’s 50-day moving average is 139.04, which suggests SRPT is a Sell.
              What is SRPT’s 200-day moving average?
              SRPT’s 200-day moving average is 125.97, which suggests SRPT is a Sell.
                What is SRPT’s Williams % R (14)?
                SRPT’s Williams % R (14) is -74.36, which suggests SRPT is a Buy.
                  What is SRPT’s CCI (14)?
                  SRPT’s CCI (14) is -92.47, which suggests SRPT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis